| Dr Siham M Mahgoub, MD | |
|
502 W Broad St Ste 2, Falls Church, VA 22046-3206 | |
| (571) 421-8431 | |
| Not Available |
| Full Name | Dr Siham M Mahgoub |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 33 Years |
| Location | 502 W Broad St Ste 2, Falls Church, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194834754 | NPI | - | NPPES |
| 02224422 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 2189841 (New York) | Secondary |
| 207R00000X | Internal Medicine | 0101239997 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Howard University | 0941109565 | 136 |
News Archive
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of COL-172 for the relief of moderate to severe pain in patients requiring continuous, around-the-clock opioid treatment for an extended period of time.
Jamie Tyler, assistant professor in the Virginia Tech Carilion Research Institute and the Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences, has been invited to speak at a Royal Society of London high level workshop on May 11-12 on the security implications of advances in neuroscience.
According to the Australasian College of Cosmetic Surgery, a just-released study of medical negligence claims between 2002 and 2008 published in the Medical Journal of Australia underlines the importance that codes of practice can play in ensuring that a proper process is observed to obtain informed consent for cosmetic surgical procedures.
Physicians have long known that necrotizing enterocolitis (NEC), a potentially lethal inflammatory condition that destroys a premature infant's intestinal lining, is often connected to the development of severe brain injury in those infants who survive.
Neurologix, Inc., announced today that the results of the Company's Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease were published in an online-first edition of The Lancet Neurology.
› Verified 6 days ago
| Entity Name | Howard University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033163597 PECOS PAC ID: 0941109565 Enrollment ID: O20040102000561 |
News Archive
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of COL-172 for the relief of moderate to severe pain in patients requiring continuous, around-the-clock opioid treatment for an extended period of time.
Jamie Tyler, assistant professor in the Virginia Tech Carilion Research Institute and the Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences, has been invited to speak at a Royal Society of London high level workshop on May 11-12 on the security implications of advances in neuroscience.
According to the Australasian College of Cosmetic Surgery, a just-released study of medical negligence claims between 2002 and 2008 published in the Medical Journal of Australia underlines the importance that codes of practice can play in ensuring that a proper process is observed to obtain informed consent for cosmetic surgical procedures.
Physicians have long known that necrotizing enterocolitis (NEC), a potentially lethal inflammatory condition that destroys a premature infant's intestinal lining, is often connected to the development of severe brain injury in those infants who survive.
Neurologix, Inc., announced today that the results of the Company's Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease were published in an online-first edition of The Lancet Neurology.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Siham M Mahgoub, MD 2041 Georgia Ave Nw # 6101, Washington, DC 20060-0001 Ph: () - | Dr Siham M Mahgoub, MD 502 W Broad St Ste 2, Falls Church, VA 22046-3206 Ph: (571) 421-8431 |
News Archive
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of COL-172 for the relief of moderate to severe pain in patients requiring continuous, around-the-clock opioid treatment for an extended period of time.
Jamie Tyler, assistant professor in the Virginia Tech Carilion Research Institute and the Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences, has been invited to speak at a Royal Society of London high level workshop on May 11-12 on the security implications of advances in neuroscience.
According to the Australasian College of Cosmetic Surgery, a just-released study of medical negligence claims between 2002 and 2008 published in the Medical Journal of Australia underlines the importance that codes of practice can play in ensuring that a proper process is observed to obtain informed consent for cosmetic surgical procedures.
Physicians have long known that necrotizing enterocolitis (NEC), a potentially lethal inflammatory condition that destroys a premature infant's intestinal lining, is often connected to the development of severe brain injury in those infants who survive.
Neurologix, Inc., announced today that the results of the Company's Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease were published in an online-first edition of The Lancet Neurology.
› Verified 6 days ago
Amita Rajani, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 3300 Gallows Road Inova Fairfax Medical Campus, Department Of Medicine, Npt-2, Falls Church, VA 22042 Phone: 703-776-7780 | |
Dr. Mary Beck O'donnell, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2960 Sleepy Hollow Rd, Falls Church, VA 22044 Phone: 703-536-2000 Fax: 703-536-4256 | |
Lindsey A. Cilia, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2901 Telestar Ct Ste 200, Falls Church, VA 22042 Phone: 703-573-3494 Fax: 703-573-5353 | |
Chin Hee Kim, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd Dept Of, Falls Church, VA 22042 Phone: 703-776-3582 | |
Candyce Heather Greene, MD, MPH, MSW Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-7113 | |
Dr. Megan Elizabeth Terek, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-7113 | |
Dr. Hazim El-haddad, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2901 Telestar Ct Ste 200, Falls Church, VA 22042 Phone: 703-573-3494 Fax: 703-573-5353 |